Pharmaceutical Executive November 1, 2023
Mike Hollan

Stark discusses pharma’s supply chain and the issues it is facing.

Pharmaceutical Executive: What are the current vulnerabilities in the supply chain for the pharma industry?

Derron Stark: It’s really the same for any industry. Geopolitical disruptions, like the war in Ukraine, have created shortages of certain key raw materials that are used in pharmaceutical manufacturing processes and those have to be sourced from other places. Then there are unique problems like the limitation on transportation truck drivers in Europe (because a lot of Ukrainians serve those roles) and energy insufficiency (because of the reliance of certain parts of Europe on Russian energy), there were certain suppliers within the pharma industry that were significantly constrained until they could overcome those...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Supply Chain, Technology, Trends
Related Articles:
The AI Software Supply Chain Is A Dumpster Fire: Here's What Companies Can Do About It
Supply chain challenges in 2025: 5 things to know
As Supply Chains Go Digital, Cybersecurity Must be Strongest Link
Digital twins: The key to unlocking end-to-end supply chain growth
Why Supply Chain Technology Keeps Failing—And How To Fix It

Share This Article